High-Probability Features of Primary Aldosteronism May Obviate the Need for Confirmatory Testing Without Increasing False-Positive Diagnoses

Journal of Clinical Hypertension

Volumn 16, Issue 7, 2014, Pages 488-496

  Kline, Gregory A ^a   Pasieka, Janice L ^b   Harvey, Adrian ^b   So, Benny ^b   Dias, Val C ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; RENIN;

ADRENAL VEIN SAMPLING; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOKALEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROBABILITY; SAMPLING; ADRENAL GLAND; BLOOD; HYPERALDOSTERONISM; LABORATORY DIAGNOSIS; MEDICAL AUDIT; MIDDLE AGED; PREDICTIVE VALUE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VASCULARIZATION; VEIN;

ADRENAL GLANDS; ADULT; ALDOSTERONE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MALE; MEDICAL AUDIT; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; RADIOIMMUNOASSAY; RENIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VEINS;

EID: 84904051005     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12342     Document Type: Article

References (36)

1. Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J. 2007;54:487-495.
2. Loh KC, Koay ES, Khaw MC, et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854-2859.
3. Lim PO, Dow E, Brennan G, et al. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens. 2000;14:311-315.
4. Stowasser M, Gordon R, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after "non-selective" screening of hypertensive patients. J Hypertens. 2003;21:2149-2157.
5. Catena C, Colussi GL, Lapenna R, et al. Long term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50:911-918.
6. Catena C, Colussi GL, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Int Med. 2008;168:80-85.
7. Meyer A, Brabant G, Behrend M. Long term follow up after adrenalectomy for primary aldosteronism. World J Surg. 2005;29:155-159.
8. Waldman J, Maurer L, Holler J, et al. Outcome of surgery for primary hyperaldosteronism. World J Surg. 2011;35:2422-2427.
9. Steichen O, Zinzindohoue F, Plouin PF, Amar L. Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res. 2012;44:221-227.
10. Bewick V, Cheek L, Ball J. Statistics Review 13: receiver operating characteristic curves. Crit Care. 2004;8:508-512.
11. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
12. Salva M, Cicala MV, Mantero F. Primary aldosteronism: the role of confirmatory tests. Horm Metab Res. 2012;44:177-180.
13. Nanba K, Tamanaha T, Nakao K, et al. Confirmatory testing in primary aldosteronism. J Clin Endocrinol Metab. 2012;97:1688-1694.
14. Willenberg HS, Vonend O, Schott M, et al. Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism. Horm Metab Res. 2012;44:527-532.
15. Westerdahl C, Bergenfelz A, Isaksson A, Valdemarsson S. Captopril suppression: limitations for confirmation of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2011;12:326-332.
16. Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91:2618-2623.
17. Sackett DL, Straus SE, Richardson WS, et al. (2000). Evidence-Based Medici≠ How to Practice and Teach EBM, 2nd ed. Edinburgh, UK: Churchill Livingstone.
18. Ayala AR, Ilias I, Nieman LK. The spectrum effect in the evaluation of Cushing syndrome. Curr Opin Endocrinol Diabetes. 2003;10:272-276.
19. Jaeschke R, Guyatt GH, Sackett DL. User's guides to the medical literature: III. How to use an article about a diagnostic test: B. What are the results and will they help me in caring for my patients? JAMA. 1994;271:703-707.
20. Harvey A, Pasieka JL, Kline GA, So B. Modification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism. Surgery. 2012;152:643-651.
21. Mahmud A, Mahgoub M, Hall M, Feely J. Does aldosterone to renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Am J Hypertens. 2005;18:1631-1635.
22. Montori VM, Young WF. Use of plasma aldosterone concentration to plasma renin activity ratio as a screening test for primary aldosteronism - a systematic review of the literature. Endocrinol Metab Clin North Am. 2002;31:619-632.
23. Kline GA, Harvey A, Jones C, et al. Adrenal vein sampling in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Int Urol Nephrol. 2008;40:1035-1043.
24. Mulatero P, Stowasser M, Loh K, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045-1050.
25. Graham UM, Ellis PK, Hunter SJ, et al. 100 cases of primary aldosteronism: careful choice of patients for surgery using adrenal venous sampling and CT imaging results in excellent blood pressure and potassium outcomes. Clin Endocrinol. 2012;76:26-32.
26. Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's registry. J Clin Endocrinol Metab. 2009;94:1125-1130.
27. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293-2300.
28. Omura M, Sasano H, Saito J, et al. Clinical characteristics of aldosterone producing microadenoma, macroadenoma and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res. 2006;29:883-889.
29. Satoh F, Abe T, Tanemoto M, et al. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res. 2007;30:1083-1095.
30. Murashima M, Trerotola SO, Fraker DL, et al. Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single centre experience. J Clin Hypertens. 1009;11:316-323.
31. Mathur A, Kemp CD, Dutta U, et al. Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. J Am Coll Surg. 2010;211:384-390.
32. Kupers EM, Amar L, Raynaud A, et al. A clinical prediction score to diagnose unilateral primary aldosteronism. J Clin Endocrinol Metab. 2012;97:3530-3537.
33. Mulatero P, Bertello C, Rossato D, et al. Roles of clinical criteria, computed tomography scan and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008;93:1366-1371.
34. Letavernier E, Peyrard S, Amar L, et al. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens. 2008;26:1816-1823.
35. Rossi GP, Belfiore A, Bernini G, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone producing adenoma. Hypertension. 2007;50:424-431.
36. Schirpenbach C, Seiler L, Maser-Gluth C, et al. Confirmatory testing in normokalemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol. 2006;154:865-873.